Evidence map›Paper›PMID 31557730›Full record

ReviewJournal of neural engineering2019

Neural engineering: the process, applications, and its role in the future of medicine.

Evon S Ereifej, Courtney E Shell, Jonathon S Schofield, Hamid Charkhkar, Ivana Cuberovic, Alan D Dorval, Emily L Graczyk, Takashi D Y Kozai, Kevin J Otto, Dustin J Tyler and 6 more

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neural engineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 23 citations in OpenAlex.

  1. User-Centered Design of Neuroprosthetics: Advancements and Limitations.CNS & neurological disorders drug targets · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 13 institutions in 2 countries.

Evon S EreifejVeteran Affairs Ann Arbor Healthcare System, Ann Arbor, MI, United States of America.ORCID 0000-0001-6340-5193
Courtney E ShellAdvanced Platform Technology Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, United States of America.ORCID 0000-0003-3764-6836
Jonathon S SchofieldDepartment of Mechanical and Aerospace Engineering, College of Engineering, University of California, Davis, Davis, CA, United States of America.ORCID 0000-0002-6422-7429
Hamid CharkhkarDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States of America.ORCID 0000-0001-5485-5969
Ivana CuberovicDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States of America.
Alan D DorvalDepartment of Biomedical Engineering, University of Utah, Salt Lake City, UT, United States of America.
Emily L GraczykDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States of America.
Takashi D Y KozaiBioengineering, University of Pittsburgh, Pittsburgh, PA, United States of America.ORCID 0000-0002-2507-3295
Kevin J OttoJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, United States of America.ORCID 0000-0002-2317-6194
Dustin J TylerDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States of America.
Cristin G WelleDepartments of Neurosurgery and Bioengineering, University of Colorado, Aurora, CO, United States of America.ORCID 0000-0001-8735-0983
Alik S WidgeDepartment of Psychiatry, University of Minnesota, Minneapolis, MN, United States of America.ORCID 0000-0001-8510-341X
José ZariffaKITE, Toronto Rehab-University Health Network, Toronto, Ontario, Canada.ORCID 0000-0002-8842-745X
Chet T MoritzElectrical and Computer Engineering, University of Washington, Seattle, WA, United States of America.
Dennis J BourbeauDepartment of Physical Medicine and Rehabilitation, MetroHealth System, Cleveland, OH, United States of America.ORCID 0000-0003-1348-4713
Paul D MarascoAdvanced Platform Technology Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, United States of America.
Louis Stokes Cleveland VA Medical Center · USCleveland Clinic Lerner College of Medicine · USAllen Institute for Brain Science · USCase Western Reserve University · USMetroHealth · USUniversity Health Network · CAUniversity of California, Davis · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Florida · USUniversity of Michigan · USUniversity of Minnesota · USUniversity of Utah · USUniversity of Washington · US

Funding

Afferent Stimulation to Evoke Recto-colonic Reflex for Colonic MotilityIK2RX001962 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI BOURBEAU, DENNIS · 2016 to 2021
–
Mimicking the Architecture and Modulus of Native Brain Tissue onto Neural Implants to Improve BiocompatibilityIK2RX002628 · VA · VETERANS HEALTH ADMINISTRATION · PI EREIFEJ, EVON S. · 2018 to 2021
–
RRD VA IK2 RX001962RRD VA IK2 RX002628
6 · The paper itself

Abstract

objectiveRecent advances in neural engineering have restored mobility to people with paralysis, relieved symptoms of movement disorders, reduced chronic pain, restored the sense of hearing, and provided sensory perception to individuals with sensory deficits. APPROACH: This progress was enabled by the team-based, interdisciplinary approaches used by neural engineers. Neural engineers have advanced clinical frontiers by leveraging tools and discoveries in quantitative and biological sciences and through collaborations between engineering, science, and medicine. The movement toward bioelectronic medicines, where neuromodulation aims to supplement or replace pharmaceuticals to treat chronic medical conditions such as high blood pressure, diabetes and psychiatric disorders is a prime example of a new frontier made possible by neural engineering. Although one of the major goals in neural engineering is to develop technology for clinical applications, this technology may also offer unique opportunities to gain insight into how biological systems operate. MAIN

resultsDespite significant technological progress, a number of ethical and strategic questions remain unexplored. Addressing these questions will accelerate technology development to address unmet needs. The future of these devices extends far beyond treatment of neurological impairments, including potential human augmentation applications. Our task, as neural engineers, is to push technology forward at the intersection of disciplines, while responsibly considering the readiness to transition this technology outside of the laboratory to consumer products. SIGNIFICANCE: This article aims to highlight the current state of the neural engineering field, its links with other engineering and science disciplines, and the challenges and opportunities ahead. The goal of this article is to foster new ideas for innovative applications in neurotechnology.

Indexed as

BioengineeringChronic DiseaseForecastingHumansInventionsNervous System Diseases

Identifiers

PMID31557730
PMCPMC7875502
OpenAlexW2976813237

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.